STERLING LIONEL N

Director at Molecular Insight Pharmaceuticals, Inc. · on record since Feb 5, 2007
Former Director at I STAT CORPORATION /DE/ · on record since Jan 30, 2004

Insider trading activity of STERLING LIONEL N

Transactions on record: 29; since Jan 30, 2004

Open-market buys: 1; $201.6K

Open-market sells: 0

Companies traded: 2; last filing May 17, 2010

Figures computed from official regulatory filings — methodology.

Companies where STERLING LIONEL N has traded

Molecular Insight Pharmaceuticals, Inc.13 tx · $341.6K · May 17, 2010
I STAT CORPORATION /DE/16 tx · Jan 30, 2004

Track record of STERLING LIONEL N

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of STERLING LIONEL N

Co-insiders of STERLING LIONEL N

FEINBERG STEPHENI STAT CORPORATION /DE/ +1
FRANK DANIELI STAT CORPORATION /DE/ +1
Abdalian Charles H JrMolecular Insight Pharmaceuticals, Inc.
Attarian Mark AMolecular Insight Pharmaceuticals, Inc.
Babich John WMolecular Insight Pharmaceuticals, Inc.
Barlow David SMolecular Insight Pharmaceuticals, Inc.
Barrett John AMolecular Insight Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Molecular Insight Pharmaceuticals, Inc.	May 17, 2010	AwardD	-25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 15, 2008	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Jun 28, 2007	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Apr 12, 2007	Buy	14,400	14.00	$201.6K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-2,652	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	38,009	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	101,199	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-860	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-1,750	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-17,680	3.96	$70K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	63,940	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	17,680	3.96	$70K	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	10,256	5.08 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-6,230	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-10,256	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-6,230	6.59 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-5,000	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	6,230	6.59 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-5,475	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-3,737	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-5,000	9.63 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-3,737	13.00 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-10,256	5.08 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	5,000	9.63 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Molecular Insight Pharmaceuticals, Inc.	May 17, 2010	AwardD	-25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 15, 2008	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Jun 28, 2007	AwardD	25,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Apr 12, 2007	Buy	14,400	14.00	$201.6K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-2,652	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	38,009	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	101,199	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-860	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-1,750	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	OtherD	-17,680	3.96	$70K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	63,940	—	—	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 5, 2007	Other	17,680	3.96	$70K	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	10,256	5.08 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-6,230	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-10,256	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-6,230	6.59 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-5,000	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	6,230	6.59 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-5,475	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Other	-3,737	15.35 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-5,000	9.63 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-3,737	13.00 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	ExerciseD	-10,256	5.08 USD	—	SEC
I STAT CORPORATION /DE/	Jan 30, 2004	Exercise	5,000	9.63 USD	—	SEC